A test that looks for genetic hallmarks of brain cancers in samples of cerebrospinal fluid can decrease the time to diagnosis and eliminate the need...
Vous n'êtes pas connecté
A genetic test detecting brain cancer markers in cerebrospinal fluid reduces diagnostic time and eliminates the need for invasive biopsies. Researchers
A test that looks for genetic hallmarks of brain cancers in samples of cerebrospinal fluid can decrease the time to diagnosis and eliminate the need...
USask spearheads cutting-edge research. SASKATOON — University of Saskatchewan (USask) researchers Dr. Changiz Taghibiglou (PhD) and Dr. Sara...
Researchers at Mayo Clinic and their collaborators have made a significant discovery in understanding Alzheimer’s disease by identifying unique...
Researchers have discovered metabolic markers that forecast cancer patients' immunotherapy responses and survival outcomes, highlighting the...
New research describes for the first time how a spreading wave of disruption and the flow of fluid in the brain triggers headaches, detailing the...
An artificial intelligence-powered method for detecting tumour DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, in a...
Trying to figure out whether someone has Alzheimer's disease usually involves a battery of assessments-;interviews, brain imaging, blood and...
Researchers at the University of Gothenburg have developed an AI model that increases the potential for detecting cancer through sugar analyses
Researchers performed a case-control study to compare metabolic changes between individuals homozygous for a loss-of-function genetic variation in...
The U.S. Food and Drug Administration (FDA) has expanded orphan drug designation for SurVaxM, a brain cancer immunotherapy born in the labs of Roswell...